Botanical drugs – what is the best way forward for regulatory and market approval?
European Pharmaceutical Review
JULY 4, 2024
11 In order to market such a product, companies must apply for a THR but it should be noted that this is only granted to eligible products; ie, those used for minor health conditions (such as a cold) and without the supervision of a medical practitioner 10 (whether for diagnostic purposes or for prescription or monitoring of treatment).
Let's personalize your content